Oramed Pharmaceuticals Inc.
2 Elza Street
Jerusalem
93706
Tel: 011-972-54-7909058
Fax: 011-972-2-6792336
Website: http://www.oramedpharma.com/
Email: info@oramedpharma.com
324 articles about Oramed Pharmaceuticals Inc.
-
Oramed Pharmaceuticals Inc. Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
5/5/2009
-
Oramed Pharmaceuticals Inc. to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the American Diabetes Association (June 5-9, New Orleans, LA)
3/25/2009
-
Oramed Pharmaceuticals Inc. Completes Proof of Concept Study of Insulin Suppository
2/4/2009
-
Oramed Pharmaceuticals Inc. Presents Results of Oral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs The Study Suggests That the GLP-1 Analog Exenatide -4 When Combined With Oramed's Absorption Promoters is Absorbed Through t
11/14/2008
-
Oramed Pharmaceuticals Inc. Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
11/4/2008
-
Oramed Pharmaceuticals Inc. Launches Phase 1A Trials of its Insulin Suppository
10/23/2008
-
Oramed Pharmaceuticals Inc. Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
9/24/2008
-
Oramed Pharmaceuticals Inc. Launches GLP1-Analog Program
9/16/2008
-
Oramed Pharmaceuticals Inc. Partners With ETI Karle Clinical to Conduct Phase 2B Trials
9/9/2008
-
Oramed Pharmaceuticals Inc. Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
8/18/2008
-
Oramed Pharmaceuticals Inc. Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule The Trial Demonstrated the Safety and Efficacy of the ORMD 0801- Oral Insulin Capsule
8/6/2008
-
Oramed Pharmaceuticals Inc. to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
7/31/2008
-
Oramed Pharmaceuticals Inc. Appoints Dr. Harold Jacob to its Board of Directors
7/28/2008
-
Oramed Pharmaceuticals Inc. Raises $5 Million Through a Private Placement
7/15/2008
-
Nobel Prize Winner Professor Avram Hershko Named to Oramed Pharmaceuticals Inc. Scientific Advisory Board
7/10/2008
-
Oramed Pharmaceuticals Inc. to Present Oral Insulin Trial Results at American Diabetes Association Conference (June 6-10, San Francisco)
6/4/2008
-
Oramed Pharmaceuticals Inc. Partners with OnQ Consulting for Phase 2B Trials on Its Oral Insulin Capsules
4/17/2008
-
Oramed Pharmaceuticals Inc. Commences Phase 2A Clinical Trials in Israel
4/14/2008
-
Oramed Pharmaceuticals Inc. Granted Approval to Conduct Phase 2A Trials of Its Oral Insulin Capsule
3/18/2008
-
Oramed Pharmaceuticals Inc. Successfully Completes Phase 1B Clinical Trials of Oral Insulin Capsule
3/11/2008